AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

TINZAPARINE

12 registrations across 1 African market— 12 active

Markets with TINZAPARINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
INNOHEP 2500 UI ANTI-XA/0,25 ML
SOLUTION INJECTABLE
🇲🇦Moroccoactive
INNOHEP 3500 UI ANTI-XA/0,35 ML
SOLUTION INJECTABLE
🇲🇦Moroccoactive
INNOHEP 18 000 UI ANTI-XA/0,9 ML
SOLUTION INJECTABLE
🇲🇦Moroccoactive
INNOHEP 14 000 UI ANTI-XA/0,7 ML
SOLUTION INJECTABLE
🇲🇦Moroccoactive
INNOHEP 2500 UI ANTI-XA/0,25 ML
SOLUTION INJECTABLE
🇲🇦Moroccoactive
INNOHEP 10 000 UI ANTI-XA/0,5 ML
SOLUTION INJECTABLE
🇲🇦Moroccoactive
INNOHEP 14 000 UI ANTI-XA/0,7 ML
SOLUTION INJECTABLE
🇲🇦Moroccoactive
INNOHEP 10 000 UI ANTI-XA/0,5 ML
SOLUTION INJECTABLE
🇲🇦Moroccoactive
INNOHEP 3500 UI ANTI-XA/0,35 ML
SOLUTION INJECTABLE
🇲🇦Moroccoactive
INNOHEP 4500 UI ANTI-XA/0,45 ML
SOLUTION INJECTABLE
🇲🇦Moroccoactive
INNOHEP 18 000 UI ANTI-XA/0,9 ML
SOLUTION INJECTABLE
🇲🇦Moroccoactive
INNOHEP 4500 UI ANTI-XA/0,45 ML
SOLUTION INJECTABLE
🇲🇦Moroccoactive

TINZAPARINE in Africa — Regulatory Overview

TINZAPARINE is registered across 1 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco. AfricaRegulatory refreshes this data daily from official government sources.

Of the 12 registrations, 12 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.